Ligand validation:2Y5Z

ZM3: MYCINAMICIN III

ZM3 is a Ligand Of Interest in 2Y5Z designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2Y5Z_ZM3_C_460	20%	18%	0.198	0.842	1.53	1.99	2	10	1	0	77%	0.6937
2Y5Z_ZM3_B_460	20%	19%	0.194	0.834	1.48	1.94	2	14	2	0	77%	0.6937
2Y5Z_ZM3_A_460	15%	18%	0.207	0.811	1.53	1.99	3	13	2	0	77%	0.6937
2YCA_ZM3_A_460	87%	33%	0.086	0.958	1.11	1.51	2	14	2	0	100%	1
4X7Z_ZM3_A_305	63%	75%	0.119	0.915	0.34	0.64	-	1	0	0	100%	1
4X7U_ZM3_B_303	55%	71%	0.125	0.892	0.41	0.71	1	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.